Inspire Medical Systems Inc (INSP)

Debt-to-equity ratio

		Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	9,795	12,798	15,799	18,799	21,801	24,804	24,746	24,689	24,632	24,576	24,522
Total stockholders’ equity	US$ in thousands	696,562	638,071	589,024	572,514	544,180	529,359	504,648	496,008	470,204	226,984	225,055	229,048	220,300	219,914	223,131	229,747	228,823	233,594	127,403	139,835
Debt-to-equity ratio		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.04	0.06	0.07	0.09	0.10	0.11	0.11	0.11	0.11	0.19	0.18

September 30, 2024 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $696,562K
= 0.00

The debt-to-equity ratio of Inspire Medical Systems Inc has shown a relatively stable trend over the past few years. The ratio was 0.00 in the most recent quarter, indicating that the company had no debt relative to its equity. This suggests a conservative capital structure with a lower risk of financial distress.

Looking back over the past quarters, the company maintained a consistent low debt-to-equity ratio, with slight fluctuations observed in the range of 0.04 to 0.19. The ratios of 0.06 to 0.11 in some quarters suggest a slight increase in debt usage compared to the recent quarter, but overall, the company appears to have managed its debt levels prudently.

The significant drop in the debt-to-equity ratio from 0.19 in the fourth quarter of 2019 to 0.00 in the most recent quarter could indicate a strategic effort by Inspire Medical Systems Inc to reduce debt levels and strengthen its financial position. Further analysis of the company's financial statements and management discussion may provide insights into the reasons behind this trend and the implications for the company's growth and profitability.